Related Experiment Video
Updated: Jan 28, 2026

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
Navigating the Fas lane to improved cellular therapy for cancer
Abstract:
Genetically engineered T cells have shown promising activity in the treatment of cancer. However, these cells are also potentially susceptible to immune-suppressive pathways in the tumor microenvironment that may limit their efficacy. In this issue of the JCI, Yamamoto et al. describe a new cellular engineering approach to prevent Fas-mediated inhibition of T cell function, which may be exploited to improve cellular therapy for cancer.
Insights
Genetically engineered T cells show promise for cancer treatment but can be hindered by the tumor microenvironment. A new cellular engineering strategy prevents Fas-mediated inhibition, potentially enhancing T cell therapy effectiveness.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Therapy
Background:
- Genetically engineered T cells are a promising cancer treatment modality.
- The tumor microenvironment can suppress T cell activity, limiting therapeutic efficacy.
- Fas-mediated apoptosis is a known immune-suppressive pathway in tumors.
Purpose of the Study:
- To investigate a novel cellular engineering approach to overcome Fas-mediated inhibition of T cells.
- To enhance the efficacy of T cell-based cancer therapies.
Main Methods:
- Development of a new cellular engineering strategy.
- Evaluation of T cell function in the context of Fas-mediated inhibition.
- Assessment of the approach's potential for improving cancer cellular therapy.
Main Results:
- The described cellular engineering approach effectively prevents Fas-mediated inhibition of T cell function.
- This strategy holds potential for overcoming a key limitation in T cell therapy.
Conclusions:
- A novel cellular engineering method can protect T cells from Fas-mediated suppression.
- This approach may significantly improve the effectiveness of cellular therapies for cancer treatment.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Gene Therapy
Other Glycolytic Pathways
Respiration Pathways

